prior authorization review panel mco policy submission a ... · cerebral palsy (cp) also known as...
TRANSCRIPT
Prior Authorization Review Panel MCO Policy Submission
A separate copy of this form must accompany each policy submitted for review. Policies submitted without this form will not be considered for review.
Plan: Aetna Better Health Submission Date: 05/01/2019
Policy Number: 0151 Effective Date: Revision Date: 02/14/2019
Policy Name: Hippotherapy
Type of Submission – Check all that apply: New Policy Revised Policy*
Annual Review – No Revisions *All revisions to the policy must be highlighted using track changes throughout the document. Please provide any clarifying information for the policy below:
CPB 0151 Hippotherapy
This CPB has been revised to state that This CPB has been revised to state that the use of hippotherapy (also known as equine therapy) is considered experimental and investigational for the treatment of low back pain and Down's syndrome.
Name of Authorized Individual (Please type or print):
Dr. Bernard Lewin, M.D.
Signature of Authorized Individual:
Proprietary
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 1 of 36
-->
(https://www.aetna.com/)
Hippotherapy
Clinical Policy Bulletins Medical Clinical Policy Bulletins
Policy History
Last Re
view
02/14/2019
Effective: 03/31/1997
Next
Review: 02/13/2020
Review
Histor
y
Definitions
Additional Information
Number: 0151
Policy *Please see amendment for Pennsylvania Medicaid at the end of this
CPB.
Aetna considers the use of hippotherapy (also known as equine therapy)
experimental and investigational for the treatment of the following indications and
all other indications because there is insufficient scientific data in the peer reviewed
medical literature to support the effectiveness of hippotherapy for the treatment of
individuals with these indications.
▪ Anxiety
▪ Attention deficit and/or hyperactivity disorder
▪ Autism
▪ Behavioral and psychiatric disorders (including aggressive violent behavior
and eating disorders)
▪ Cerebral palsy or other motor dysfunctions (e.g., arthritis, balance deficits,
children with psychomotor impairment, head injury, multiple sclerosis,
spinal cord injury, and stroke)
▪ Down's syndrome
▪ Low back pain
▪ Post-traumatic stress disorder
▪ Rehabilitation of cancer survivors
▪ Sexual abuse and emotional stress
▪ Substance abuse disorder
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 2 of 36
Background
Cerebral palsy (CP) also known as static encephalopathy, refers to a wide variety of
non-progressive brain disorders resulting from insults to the central nervous system
during the perinatal period. The management of the motor dysfunction of patients
with CP includes the conventional orthopedic approach of range of motion, stretch,
and strengthening, as well as neurodevelopmental treatment. A general objective of
physiotherapy for children with CP is to reduce the influence of abnormal muscle
tone and facilitate the emergence of normal postural and movement components.
For many children with CP or other motor dysfunction, physical therapy is a long
and arduous process. In order to sustain patients’ interest and enthusiasm in their
continuing treatment, therapists have developed adjunctive therapeutic activities
such as dancing, swimming, and horseback riding.
Hippotherapy, also known as therapeutic horseback riding, equine-facilitated
therapy, or horse therapy, is the passive use of the physical movements of the
horse in the treatment of patients with neurological or other disabilities. This is
often performed under the direct supervision of a physical therapist or occupational
therapist who is horse-knowledgeable. By using the horse as a treatment modality,
the therapist tries to facilitate normal muscle tone and inhibit abnormal posture.
The therapist may place the patient in a variety of positions on the horse such as
prone across horse, prone lengthwise with hips abducted and knees flexed, side
sitting, or sitting. It is believed that the rhythmic, swinging movement of the horse
enhances balance, co-ordination, and motor development. Patients who participate
in therapeutic riding include not only children with CP, but also individuals with
arthritis, multiple sclerosis, head injury, and stroke. The horse is usually led at a
walking or trotting pace by a skilled equestrian to ensure safety and expert handling
of the animal. Assistants are present, usually one on each side, to help
repositioning or stabilizing the patient. For more severely disabled patients, the
therapist may also serve as a back rider.
For children with CP, hippotherapy utilizes the basic principles of Rood, Bobaths
(individuals who had put forth/developed neurodevelopment treatment concepts for
neuromuscular dysfunction), and proprioceptive neuromuscular facilitation. It is
believed that therapeutic horseback riding can reduce spasticity, maintain and
increase range of motion in the upper extremities of these children. Haskin and
colleagues (1982) described the benefits of a hippotherapy program (30 mins per
week) in a 5-year old patient who has participated in this type of therapy since she
was 2 1/2. Improvements included strengthening of the back and neck, better
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 3 of 36
balance, ability to sit up longer, less spasticity in the lower extremities, the legs are
externally rotated and abducted, and the feet are dorseflexed. However, the
patients also swam once a week and received physical therapy for her lower
extremities 6 days a week. Thus, it is unclear whether the observed improvements
were due to hippotherapy, adjunctive therapeutic swimming, intensive physical
therapy, and/or the result of natural growth and development.
Using a repeated-measured design, Bertoti (1988) assessed postural changes in
11 children (4 girls and 7 boys, aged 28 to 114 months) with spastic CP after
participation in a 10-week hippotherapy program (1-hour session, 2 times per week).
Evaluation of posture was carried out 3 times by 3 pediatric physical therapists -- (i)
pretest-1 followed by a 10-week period of no riding, (ii) pretest-2
followed by a 10-week therapeutic riding program, and (iii) post-test. A
composite score for each test period was computed for each patient, and a median
score was calculated for the entire group at each test period. A statistical
difference was observed among the 3 test periods with significant improvement
occurring during the period of hippotherapy. Subjective clinical improvements such
as reduced hypertonicity, as well as improved weight-bearing and functional
balance skills were reported by parents and referring physical therapists. These
findings represented the first objective report that hippotherapy may have beneficial
effect on the posture of children with spastic CP. However, the author concluded
that further investigation is needed to isolate additional variables such as range of
motion, balance, weight shift, and strength, and to evaluate the effects of
hippotherapy on different disabilities.
In an article on hippotherapy, Tuttle (1987) stated that research on the effect and
application of the various forms of therapeutic horseback riding is needed to refine
program planning, and to support funding and third-party reimbursement.
Furthermore, a workshop on “The Health Benefits of Pets” sponsored by the
National Institutes of Health concluded that “solid data on the success of
therapeutic riding is limited. ... Future research is indicated to compare the efficacy
of therapeutic riding with other clinical treatment procedures that do not involve the
horse and to validate dramatic clinical observations” (NIH, 1983). Additionally, in
an article published in the Journal of American Veterinarian Medicine Association,
Potter and colleagues (1994) stated that “Lack of scientific documentation of the
benefits of therapeutic riding is a major obstacle that must be overcome. ...
Research is critically needed in all aspects of therapeutic riding”.
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 4 of 36
Debuse et al (2005) noted that despite a substantial body of anecdotal and clinical
evidence for its benefits, research evidence for hippotherapy is sparse. In a
questionnaire survey, these researchers explored the views of physiotherapists and
people with CP who use hippotherapy. This study was aimed to: (i) establish the
pattern of hippotherapy practice in Germany and the U.K.; (ii) examine the
perceived main effects of hippotherapy on people with CP in Germany and the
U.K.; and (iii) investigate how these effects are being measured in both
countries. The results highlighted considerable differences in how hippotherapy is
practiced in the U.K. compared with in Germany. In spite of this, the study revealed
agreement among respondents on the overall perceived effects of hippotherapy on
individuals with CP, namely, the regulation of muscle tone, improvement of postural
control and psychological benefits. The results also indicated scant use of outcome
measures to evaluate these effects.
Casady and Nichols-Larsen (2004) examined if hippotherapy has an effect on the
general functional development of children with CP. The study employed a repeated-
measures design with 2 pre-tests and 2 post-tests conducted 10 weeks apart using
the Pediatric Evaluation of Disability Inventory (PEDI) and the Gross Motor Function
Measure (GMFM) as outcome measures. A convenience sample of 10 children with
CP participated whose ages were 2.3 to 6.8 years at baseline (mean +/- SD 4.1 +/-
1.7). Subjects received hippotherapy once-weekly for 10 weeks between pre-test 2
and post-test 1. Test scores on the GMFM and PEDI were compared before and
after hippotherapy. The authors concluded that results of this study suggest that
hippotherapy has a positive effect on the functional motor performance of children
with CP. Hippotherapy appears to be a viable treatment strategy for therapists with
experience and training in this form of treatment and a means of improving functional
outcomes in children with CP, although specific functional skills were not investigated.
There are 2 main drawbacks with this study: (i) the GMFM scorers were not
blinded to the order of test date and they were allowed to keep the scores
sheets, which may have biased the scorers, and (ii) with the individualized
approach to treatment, there is no protocol that would allow replication of this
study. The authors stated that hippotherapy has the potential to be a valuable
treatment strategy in treating children with CP. Future studies should use more
homogeneous patient populations in terms of age and type of CP to ascertain
precise areas of function affected most by hippotherapy.
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 5 of 36
In a review on the use of complementary and alternative therapies for the treatment
of children with CP, Liptak (2005) noted that although studies of hippotherapy have
shown beneficial effects on body structures and functioning, unanswered questions
remain. For example, it is unclear which subgroups of children with CP would
benefit the most, what "dose" or frequency of intervention is optimal.
An assessment of the evidence for hippotherapy by the Institute for Clinical
Effectiveness and Health Policy (Pichon Riviere et al, 2006) concluded: "The
efficacy of this therapy does not seem to have been sufficiently proven for any
specific indication. Its recreational role and impact on the quality of life of these
patients have not been sufficiently analyzed."
Snider et al (2007) performed a systematic review of the literature on hippotherapy
as an intervention for children with CP. Retrieved articles were rated for
methodological quality using Physiotherapy Evidence Database (PEDro) scoring to
assess the internal validity of randomized trials and the Newcastle Ottawa Quality
Assessment Scale to assess cohort studies. Population, Intervention, Comparison,
and Outcomes (PICO) questioning was used to identify questions of interest to
clinicians for outcomes within the context of the International Classification of
Functioning, Disability and Health. Levels of evidence were then accorded each
PICO question. The authors reported that there is Level 2a evidence that
hippotherapy has short-term positive effects on muscle symmetry in the trunk and hip
and that hippotherapy is effective for improving muscle tone in children with CP when
compared with regular therapy or time on a waiting list. However, no studies
addressed participation outcomes. (Note: Level 2a evidence refers to 1 or more
"fair" quality randomized controlled trials [PEDro = 4 to 5]; 6 to 8 is considered
"good"; and 9 to 10 is considered "excellent"). An assessment of this systematic
evidence review by the Centre for Reviews and Dissemination (2009) found that this
systematic review was "poorly reported" and that, "given the potential for error or
bias during the review process, these cautious conclusions may not be reliable." In
particular, the authors did not report how many reviewers carried out study selection
and data extraction. Conclusions are limited due to heterogeneity of the primary data,
small sample sizes, and limited generalization of the patient samples.
Hamill et al (2007) examined the effects of a once-weekly, 10-week hippotherapy
program for 3 children, aged 27 to 54 months, with CP. Participants were rated as
Level V on the Gross Motor Function Classification System. The Sitting Dimension
of the Gross Motor Function Measure was used to establish a baseline of sitting
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 6 of 36
abilities, and was administered every 2 weeks during intervention. The Sitting
Assessment Scale and the Gross Motor Function Measure were administered
before, after, and 4 weeks post-intervention. Parental perceptions of the
hippotherapy intervention were assessed using questionnaires. None of the
children made gains on any of the standardized outcome measures. However,
parental perceptions were very positive, with reported improvements in range of
motion and head control.
Lechner et al (2007) examined the effect of hippotherapy on spasticity and on
mental well-being of persons with spinal cord injury (SCI) and compared it with the
effects of other interventions. A volunteer sample of 12 people with spastic SCI
(American Spinal Injury Association Grade A or B) were included in this study;
interventions consisted of hippotherapy, sitting astride a Bobath roll, and sitting on a
stool with rocking seat. Each session lasted 25 mins and was conducted twice-
weekly for 4 weeks; the control condition was spasticity measurement without
intervention. Main outcome measures were clinical rating by a blinded examiner of
movement-provoked muscle resistance, using the Ashworth Scale; self-rating of
spasticity by subjects on a VAS; and mental well-being evaluated with the self-rated
well-being scale Befindlichkeits-Skala of von Zerssen. Assessments were performed
immediately after intervention sessions (short-term effect); data from the
assessments were analyzed 3 to 4 days after the sessions to calculate the long-
term effect. By analyzing the clinically rated spasticity, only the effect of hippotherapy
reached significance compared with the control condition (without intervention);
median differences in the Ashworth scores' sum before and after hippotherapy
sessions ranged between -8.0 and +0.5. There was a significant difference between
the spasticity-reducing effect of hippotherapy and the other 2 interventions in self-
rated spasticity by VAS; median differences of the VAS before and after hippotherapy
sessions ranged between -4.6 and +0.05cm. There were no long-term effects on
spasticity. Immediate improvements in the subjects' mental well-being were detected
only after hippotherapy (p = 0.048). The authors concluded that hippotherapy is
more efficient than sitting astride a Bobath roll or on a rocking seat in reducing
spasticity temporarily. Hippotherapy had a positive short-term effect on subjects'
mental well-being. The major drawbacks of this study were its small sample size and
that hippotherapy had no long-term effects on spasticity.
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 7 of 36
Sterba (2007) reported on a review of evidence for hippotherapy in CP and
concluded that hippotherapy and horseback riding are effective in improving gross
motor skills. However, a critical assessment of this evidence review by the Centre
for Reviews and Dissemination (CRD, 2008) stated that "given the methodological
limitations of both included studies and the review, these conclusions should be
treated with caution." The CRD found insufficient information about the study
selection, data extraction and quality assessment process to determine whether
these had been carried out independently by more than one reviewer, "thus the
possibility of bias cannot be ruled out." The CRD stated that methodological
limitations evident in the included studies were: the inclusion of participants with
developmental disabilities other than cerebral palsy, lack of statistical analysis,
small sample sizes, use of outcome measures which have not been proven reliable
or valid, and the possibility of bias. The CRD found that "study quality and study
design do not appear to have been considered sufficiently when interpreting the
results."
McGibbon and colleagues (2009) investigated the immediate effects of 10 mins of
hippotherapy, compared with 10 mins of barrel-sitting, on symmetry of adductor
muscle activity during walking in children with CP (phase I; n = 47). These
researchers also investigated the long-term effects of 12 weekly sessions of
hippotherapy on adductor activity, gross motor function, and self-concept (phase II;
n = 6). Main outcomes measures were: for phases I and II -- adductor muscle
activity measured by surface electromyography; for phase II -- gross motor function
and self-perception profiles. In the phase I study, hippotherapy significantly
improved adductor muscle asymmetry (p < 0.001; d = 1.32). Effects of barrel-sitting
were not significant (p > 0.05; d = 0.10). In the phase II study, after 12 weeks of
hippotherapy, testing in several functional domains showed improvements over
baseline that were sustained for 12 weeks post-treatment. The authors concluded
that hippotherapy can improve adductor muscle symmetry during walking and can
also improve other functional motor skills.
McGee and Reese (2009) examined the immediate effects of a hippotherapy
session on temporal and spatial gait parameters in children with spastic CP.
Subjects comprised 9 children with a diagnosis of CP (6 girls and 3 boys, 7 to 18
years of age). Data for temporal and spatial gait parameters were collected
immediately before and after a hippotherapy session. No statistically significant
differences (p < 0.05) were noted in the post-ride temporal and spatial gait
parameter values when compared with the pre-ride values. The authors concluded
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 8 of 36
that the findings of this study provide baseline data for future research and useful
clinical information for physical therapists using hippotherapy as a treatment
modality for children with spastic CP.
Schwesig et al (2009) tested the hypothesis that hippotherapy has both positive
short- and long-term effects on gait and posture control of persons suffering from
motoric disabilities. A total of 22 children and adolescents aged 9.69 +/- 4.01 years
(range of 9.69 +/- 4.01 years) with motoric dysfunctions were included in a
prospective matched-control study. In each participant, gait and posture control
were investigated on 4 different occasions (O1 to O4) using the Interactive balance
system and the portable gait analysis system RehaWatch. The dates of gait and
posture analysis were defined as follows: O1: immediately prior to first therapeutic
riding session (TRS); O2: immediately after first TRS; O3: after the last day of an
8-week period of daily TRS; O4: 7 weeks later after a TRS-free interval. The
following parameters were slightly improved (adjusted significance level of p <
0.003) after 8 weeks of therapeutic riding: (O1 versus O 3): (i) walking distance (p
= 0.009, eta (2) = 0.339); (ii) pace frequency (p = 0.007, eta (2) = 0.358); and (iii)
walking speed (p = 0.006, eta (2) = 0.367), and (iv) time of attachment (p = 0.007,
eta (2) = 0.360). The only short-term effect observed was a significant decrease of
the attachment phase (p = 0.002, eta (2) = 0.387). Interestingly, gait symmetry
remained unaffected. Posturography (adjusted significance level of p < 0.01) at O1
versus O2 (short-term) showed a significant decrease of the performance of both
the visual-nigrostriatal subsystem (p < 0.001) and the somato-sensory subsystem
(p = 0.001). At O1 versus O3 (long-term), the following parameters were sharply
decreased: (i) postural stability (p = 0.011), and (ii) somato-sensory performance
(p = 0.011). The authors concluded that in the individuals investigated, an 8-week
series of therapeutic riding did not improve posture control and had only a small
positive effect on gait performance. The reasons for these rather disappointing
results could have been the low number of therapeutic riding sessions (0.5
sessions per week), and the relatively short duration (30 mins) of each session. It
remains to be seen, whether a higher density and longer duration of therapeutic
riding sessions yields better results.
Oppenheim (2009) stated that there are no published studies specifically
addressing complementary and alternative methods (CAM) in adults with CP.
However, national surveys of adults with chronic disabilities document that a
majority of them use such treatments, that they are willing to pay out of pocket, if
necessary, and that they believe that pursuing such treatment relieves pain,
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 9 of 36
reduces stress and anxiety and leads to improved feelings of fitness and well-
being. Individuals enjoy taking charge of their own health care decisions, and
frequently feel more in control with these therapies than with more traditional
methods. In contrast to adults, there is some information on CAM in children with
CP. The author discussed some of the CAM used in children that may be carried
over into adulthood, as well as the pitfalls for patients and conventional physicians
as they try to sort out what might be helpful and what might be harmful in this
arena. Practitioners of both conventional and CAM therapies believe that exercise
can be beneficial; accordingly, activities such as recreational sports, yoga, and
hippotherapy may be continued from childhood into adulthood. General treatments
for stress and anxiety, through such activities as yoga and meditation, though not
directed at CP per se, may be more popular for adults than children. Research in
this area should first identify what methods are being utilized and then subject
these methods to well-designed outcome studies that take into account any
associated risks.
Johnson (2009) analyzed evidence of the benefits of physical activity for youth with
developmental disabilities. A total of 3,263 citations was found. Systematic
reviews and articles about studies quantitatively examining the effects of physical
activity in youth with developmental disabilities aged 0 to 20 years were included.
Only articles published in English in peer-reviewed journals were included; 3
systematic reviews and 14 studies were reviewed. Strong evidence indicated that
children and adolescents with developmental disabilities derive health benefits from
participation in group exercise programs, treadmill training, or hippotherapy. Lesser
levels of evidence indicated that health benefits might be present for adapted skiing
or aquatic programs. Documented benefits of physical activity include
improvements in aerobic capacity, improved gross motor function, and high levels
of participant/parent satisfaction. The author stated that further research studies
are needed that are of greater scientific rigor including larger sample sizes, control
groups, and stringent, replicable methodology.
More scientific evidence, especially controlled studies with outcome measures, is
needed to ascertain the effectiveness of hippotherapy for the treatment of CP, MS,
and other motor dysfunction.
In a pilot study, Shurtleff and Engsberg (2010) evaluated the effectiveness of
hippotherapy in improving head/trunk stability in children with CP. The participants
were 6 children with spastic diplegia and 6 children without disability. Head and
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 10 of 36
trunk stability was challenged by using a motorized barrel and measured by a video
motion capture system before and after a 12-week intervention of 45-min of
hippotherapy a week. The variables measured were anterior-posterior (AP)
translation of the head, and spine at 5 points and average AP head angles. At pre-
testing, children with CP demonstrated significant differences in AP translation and
AP head rotation compared with children without disability. Following hippotherapy,
children with CP demonstrated significant reductions in head rotation and AP
translation at C7, eye, and vertex. At post-testing, translation at C7 did not differ
significantly between children with CP and children without disability. After
hippotherapy intervention, children with CP reduced their AP head rotation and
translation, suggesting that they had increased stability of the head and trunk in
response to perturbations at the pelvis. The findings suggested that hippotherapy
might improve head and trunk stability in children with CP. These preliminary
findings need to be validated by well-designed studies with more subjects and
follow- up.
Bronson et al (2010) reviewed the evidence for hippotherapy as an intervention to
improve balance in persons with MS. Major electronic databases were searched
for articles relating to hippotherapy, MS and balance. Only full-length articles
published in peer reviewed journals that were written in English or translated into
English were included. Articles were assessed using a modified quality index that
was used for descriptive purposes only and did not exclude any study from the
review. All studies examined in this review were either case-control or case-series.
Collectively, all 3 studies reported improvements in balance. Pre-test and post-test
Berg Balance Scale scores in 2 studies revealed that primary progressive MS
demonstrated the greatest amount of change after hippotherapy compared to other
subtypes of MS. The authors concluded that hippotherapy has a positive effect on
balance in persons with MS and has an added benefit of enhancing quality of life.
They stated that data are limited, and further research will lead to a greater
knowledge base and has the potential to increase accessibility for hippotherapy to
be used as a rehabilitation modality.
Munoz-Lasa et al (2011) examined the effect of THR on the balance and gait of
ambulatory patients with MS. A total of 27 subjects were included in the study.
Patients were divided into 2 groups: (i) 12 underwent THR, and (ii) 15 traditional
physiotherapy (for both groups, 2 series of 10 weekly sessions were
performed). Before and after the study period, the following outcome measures
were applied: Extended Disability Status Scale (EDSS), Barthel Index, Tinetti
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 11 of 36
Performance-Oriented Mobility Assessment (POMA). In addition, patients of the
THR group underwent a gait analysis to assess spatiotemporal gait parameters and
ground reaction forces. The THR group showed a significant improvement in POMA
scores (p < 0.005) and 2 gait parameters: stride time (p < 0.04) and ground reaction
forces (p < 0.01). No statistically significant change was found in the control
group. The authors concluded that the results of the study showed that THR can
improve balance and gait of ambulatory patients with MS. Moreover, they stated
that these findings are preliminary, but promising and in line with the recent
literature.
In a meta-analysis, Zadnikar and Kastrin (2011) examined the effects of
hippotherapy and therapeutic horseback riding (THR) on postural control or balance
in children with CP. To synthesize previous research findings, a systematic review
and meta-analysis were undertaken. Relevant studies were identified by systematic
searches of multiple online databases from the inception of the database through
to May 2010. Studies were included if they fulfilled the following criteria:
▪ quantitative study design,
▪ investigation of the effect of hippotherapy or THR on postural control or
balance, and
▪ the study group comprised children and adults with CP.
The selected articles were rated for methodological quality. The treatment effect
was coded as a dichotomous outcome (positive effect or no effect) and quantified
by odds ratio (OR). The pooled treatment effect was calculated using a random-
effects model. Meta-regression of the effect size was performed against study co-
variates, including study size, publication date, and methodological quality score.
From 77 identified studies, 10 met the inclusion criteria. Two were excluded
because they did not include a comparison group. Therapy was found to be
effective in 76 out of 84 children with CP included in the intervention groups. The
comparison groups comprised 89 children: 50 non-disabled and 39 with CP. A
positive effect was shown in 21 of the children with CP in the comparison group
regardless of the activity undertaken (i.e., physiotherapy, occupational therapy,
sitting on a barrel or in an artificial saddle). The pooled effect size estimate was
positive (OR 25.41, 95 % confidence interval [CI]: 4.35 to 148.53), demonstrating a
statistically significant effectiveness of hippotherapy or THR in children with CP (p <
0.001). Meta-regression of study characteristics revealed no study-specific factors.
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 12 of 36
The authors concluded that the 8 studies found that postural control and balance
were improved during hippotherapy and THR. They stated that although the
generalization of their findings may be restricted by the relatively small sample size,
the results demonstrated that riding therapy is indicated to improve postural control
and balance in children with CP.
Whalen and Case-Smith (2012) examined the effectiveness of hippotherapy or
THR on motor outcomes in children with CP. Databases were searched for clinical
trials of hippotherapy or THR for children with CP. A total of 9 articles were
included in this review. Although the current level of evidence is weak, this
synthesis found that children with spastic CP, Gross Motor Function Classification
System (GMFCS) levels I to III, aged 4 years and above are likely to have
significant improvements on gross motor function as a result of hippotherapy and
THR. Evidence indicated that 45-min sessions, administered once-weekly for 8 for
10 weeks, resulted in significant effects. The authors concluded that the current
literature on hippotherapy and THR is limited. They stated that large randomized
controlled trials (RCTs) using specified protocols are needed to more conclusively
determine the effects on children with CP.
Tseng et al (2013) evaluated the literature on the effectiveness of equine-assisted
activities and therapies (EAAT) on gross motor outcomes representing the ICF
component of body functions and activity in children with CP. These investigators
conducted a systematic review and meta-analysis of RCTs and observational studies
of hippotherapy (HPOT) and THR for children with spastic CP. Gross motor
outcomes, assessed via muscle activity and muscle tone, gait, posture and GMFM
were evaluated. A total of 5 THR studies and 9 HPOT studies were included. This
meta-analysis indicated that short-term HPOT (total riding time 8 to 10 mins)
significantly reduced asymmetrical activity of the hip adductor muscles. HPOT could
improve postural control in children with spastic CP, GMFCS level of less than 5.
However, the evidence did not show a statistically significant effect on GMFM after
long-term HPOT or THR (total riding time, 8 to 22 hrs) in children with spastic CP.
The authors concluded that this systematic review found insufficient evidence to
support the claim that long-term THR or HPOT provides a significant benefit to
children with spastic CP. They found no statistically significant evidence of either
therapeutic effect or maintenance effects on the gross motor activity status in CP
children.
Hippotherapy has also been used in the treatment of patients with autism.
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 13 of 36
However, there is a lack of reliable scientific evidence regarding its effectiveness.
In a pilot study, Manikowska (2013) examined the effect of hippotherapy on spatio-
temporal parameters of gait in children with CP. A total of 16 ambulatory CP children
(GMFCS Level I to III; female: 10, male: 6; age of 5.7 to 17.5 years) qualified for
hippotherapy were investigated. Basic spatio-temporal parameters of gait, including
walking speed, cadence, step length, stride length and the left-right symmetry, were
collected using a 3-dimensional accelerometer device (DynaPort MiniMod) before
and immediately after a hippotherapy session. The Wilcoxon test was used to verify
the differences between pre- and post-session results. Changes of walking speed
were statistically significant. With the exception of step length, all spatio-temporal
parameters improved, i.e., were closer to the respective reference ranges after the
session. However, these changes were not statistically significant. The authors
concluded that 1 session of hippotherapy may have a significant effect on the spatio-
temporal parameters of gait in children with CP. The findings of this small, pilot study
need to be validated by well-designed studies.
In a single-blind RCT, Beinotti et al (2013) examined the impact of horseback riding
therapy (HBRT) on the quality of life (QOL) of individuals with hemiparesis after
stroke. A total of 24 post-stroke patients were assigned to the experimental (n =
12) and control (n = 12) groups. The control group participated in a conventional
physiotherapy program, whereas the experimental group participated in
physiotherapy plus HBRT sessions for 16 weeks. The patients were evaluated by
means of the SF-36. Data analysis was applied through the use of descriptive and
inferential statistics, with a 5 % level of significance. Significant improvement was
observed in the total score of the SF-36 in the experimental group when compared
with the control group. The combination of conventional physiotherapy and HBRT
was associated with improvements in functional capacity (p = 0.02), physical
aspects (p = 0.001), and mental health (p = 0.04) of the stroke patients. The
authors concluded that supplementation of conventional physiotherapy with HBRT,
applied in different contexts, may yield positive QOL outcomes for people with
stroke. These investigators recommended that further studies be carried out to
clarify the benefits of HBRT applied singly.
Homnick et al (2013) examined the effect of an 8-week therapeutic riding (TR)
program on measures of balance and QOL in community-dwelling older adults with
established balance deficits. The study was conducted at a Professional
Association of Therapeutic Horsemanship (PATH) International Premier riding
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 14 of 36
center. Subjects comprised 9 adults (5 females, 4 males) with a mean age of 76.4
years (range of 71 to 83). Treatment included an 8-week observation period
followed by an 8-week TR program consisting of 1 hour/week of supervised
horseback riding and an 8-week follow-up period. Subjects received balance
testing at weeks 0, 8, 16, and 24 using the Fullerton Advanced Balance Scale
(FABS), and QOL was measured at weeks 8 and 16 using the Rand SF-36 QOL
measure. Outcome measures were change in the FABS and Rand SF-36. There
was no significant difference in balance scores between the start and end of the
observation period. There was a significant improvement in the balance score and
perception of general health from the start to the end of the intervention period, and
no significant difference between the end of the intervention and the end of study,
suggesting that improvements may have been sustained. The authors concluded
that TR is a safe activity for older adults with mild-to-moderate balance deficits and
leads to both improvements in balance and QOL. Moreover, they stated that longer
and larger studies are needed to ascertain the benefit of equine-assisted activities
on improvements in balance and reduction in fall risk.
Dezutti (2013) noted that patients with eating disorders may have the most complex
inter-disciplinary treatment plans of any mental illness. Nurses need innovative
evidence-based treatment interventions to assist their patients with eating disorders
on their road to recovery. Although much has been written about equine-assisted
psychotherapy (EAP) and equine-facilitated psychotherapy, the literature has not
described a detailed session that can help nurses understand how this experiential
treatment works and the impact it can have on the patient.
In a pilot study, Cerulli et al (2014) evaluated the physiologic and psychological
effects of an equine-assisted therapy (EAT) protocol in breast cancer survivors. A
total of 20 women (mean age of 45.61 ± 2.71 years) whose breast cancer treatment
had concluded at least 6 months previously underwent a screening protocol to
certify their eligibility to participate in non-competitive sports. The patients were
randomly assigned to an intervention group (n = 10) or a control group (n = 10).
Intervention patients participated in a 16-week EAT protocol consisting of 2 hours of
activity per week. All patients were tested before and after the intervention for
maximal oxygen consumption (VO2max), fat mass percentage, total body water
percentage, strength of principal muscular groups (measured on 5 weight-lifting
machines [leg press, leg extension, leg curl, shoulder press, vertical traction]), and
quality of life using the Functional Assessment of Chronic Illness Therapy-Fatigue
questionnaire (FACIT-F). After intervention, the intervention group showed an
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 15 of 36
improvement in VO2max (28.29 %; p < 0.001), a decrease in fat mass percentage
(change, -7.73 %; p < 0.002), an increase in total body water percentage (6.90 %; p
= 0.027), and an increase in strength (leg press, 17.75 % [p = 0.018]; leg extension,
21.55 % [p = 0.005]; leg curl, 26.04 % [p < 0.001]; shoulder press, 49.72 % [p =
0.003]; vertical traction, 19.27 % [p = 0.002]). Furthermore, the increase in the 3
FACIT-F scores (FACIT-F trial outcome: 9.29 % [p = 0.010]; Functional Assessment
of Cancer Therapy-General total score, 14.80 % [p = 0.022]; and FACIT-F total score,
11.48 % [p =0.004]) showed an increase in quality of life. No significant changes for
any variable were found for the control group. The authors concluded that EAT had
positive effects on both physiologic and psychological measures, enhancing quality of
life of breast cancer survivors. They stated that these results suggested a new
method for rehabilitation intervention strategies after cancer in a non-medical
environment. These findings from a pilot study need to be validated by well-designed
studies.
Nurenberg et al (2015) stated that animal-assisted therapy (AAT), most frequently
used with dogs, is being used increasingly as an adjunctive alternative treatment for
psychiatric patients. Animal-assisted therapy with larger animals, such as horses,
may have unique benefits. In this randomized controlled study, equine and canine
forms of AAT were compared with standard treatments for hospitalized psychiatric
patients to determine AAT effects on violent behavior and related measures. The
study included 90 patients with recent in-hospital violent behavior or highly
regressed behavior. Hospitalization at the 500-bed state psychiatric hospital was 2
months or longer (mean of 5.4 years). Participants were randomly selected to
receive 10 weekly group therapy sessions of standardized EAP, canine-assisted
psychotherapy (CAP), enhanced social skills psychotherapy, or regular hospital
care. Participants' mean age was 44, 37 % were female, 76 % had diagnoses of
schizophrenia or schizoaffective disorder, and 56 % had been committed
involuntarily for civil or forensic reasons. Violence-related incident reports filed by
staff in the 3 months after study intake were compared with reports 2 months pre-
intake. Interventions were well-tolerated. Analyses revealed an intervention group
effect (F = 3.00, df = 3 and 86, p = 0.035); post-hoc tests showed specific benefits
of EAP (p < 0.05). Similar AAT effects were found for the incidence of 1:1 clinical
observation (F = 2.70, df = 3 and 86, p = 0.051); post-hoc tests suggested benefits
of CAP (p = 0.058) as well as EAP (p = 0.082). Co-variance analyses indicated
that staff can predict which patients are likely to benefit from EAP (p = 0.01). The
authors concluded that AAT, and perhaps EAP uniquely, may be an effective
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 16 of 36
therapeutic modality for long-term psychiatric patients at risk of violence. These
preliminary findings need to be validated by well-designed studies with longer
follow-up.
Del Rosario-Montejo et al (2015) stated that equine therapy is used to treat patients
susceptible to psychomotor delays. These researchers examined development of
gross motor function compared to other psychomotor skills in patients undergoing
this therapy and analyzed how this improvement affects general health status and
quality of life. The study included 11 children with delayed psychomotor
development (aged 8.82 ± 3.89; 6 boys, 5 girls). The main study variables were
gross motor function (GMFM-88) and perceived quality of life (Pediatric Quality of
Life Inventory, PedsQL). Three measurements were performed: (i) before and after
a period of inactivity, (ii) 2 months after the second measurement, and (iii) following
completion of a sustained period of therapy.
These investigators observed significant differences in overall results on the GMFM-
88 between the initial and final tests and between the intermediate and final tests.
Regarding the PedsQL quality of life scale, no statistically significant results were
recorded. The authors concluded that noticeable changes in motor control were
recorded throughout the course of the intervention, which suggested that equine
therapy may be appropriate treatment in cases of delayed psychomotor
development. These preliminary findings need to be validated by well-designed
studies.
Cerebral Palsy
Dewar et al (2015) evaluated the efficacy and effectiveness of exercise interventions
that may improve postural control in children with CP. These investigators performed
a systematic review using American Academy of Cerebral Palsy and Developmental
Medicine (AACPDM) and Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) methodology. Six databases were searched using the
following keywords: ('cerebral palsy' OR ‘brain injury'); AND ('posture*' OR 'balance'
OR 'postural balance' [MeSH]); AND ('intervention' OR 'therapy' OR 'exercise' OR
'treatment'). Articles were evaluated based on their level of evidence and conduct.
Searches yielded 45 studies reporting 13 exercise interventions with postural control
outcomes for children with CP. Five interventions were supported by a moderate
level of evidence: gross motor task training, hippotherapy, treadmill training with no
body weight support (no-BWS), trunk-targeted training, and reactive balance training.
Six of the interventions had
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 17 of 36
weak or conflicting evidence: functional electrical stimulation (FES), hippotherapy
simulators, neurodevelopmental therapy (NDT), treadmill training with body weight
support, virtual reality, and visual biofeedback. Progressive resistance exercise
was an ineffective intervention, and upper limb interventions lacked high-level
evidence. The authors concluded that the use of exercise-based treatments to
improve postural control in children with CP has increased significantly in the last
decade. Improved study design provided more clarity regarding broad treatment
efficacy. Moreover, they stated that research is needed to establish links between
postural control impairments, treatment options, and outcome measures. Low-
burden, low-cost, child-engaging, and mainstream interventions also need to be
explored.
An UpToDate review on “Management and prognosis of cerebral palsy” (Miller,
2015) states that “Not recommended -- In a comprehensive review, physical therapy
approaches that were not recommended because of lack of efficacy include
neurodevelopmental therapy (NDT) and sensory integration therapy (SIT). NDT is
the direct passive handling of limbs by the therapist, with guidance intended to
normalize the patterns of movement. It is not recommended because of the
availability of more effective alternatives. Any gains in range of motion that are
achieved during an NDT session do not carry over. Better functional gains are
achieved with motor-learning approaches, and BTX is more effective than NDT for
managing spasticity. Similarly, systematic reviews conclude that SIT is not effective
and should be replaced by effective alternatives such as those listed above. Many
other activities' interventions are supported only by low-quality or inconclusive
evidence, precluding a recommendation for or against their use.
Among these, early intervention for motor outcomes is a promising approach
because of supporting evidence in populations without CP. Interventions with weak
evidence are animal-assisted therapy, assistive technology, hippotherapy
(therapeutic horse-riding) …..
Behavioral and Psychiatric Disorders
Anestis et al (2014) stated that equine-related treatments (ERT) for mental
disorders are becoming increasingly popular for a variety of diagnoses; however,
they have been subjected only to limited systematic investigation. These
researchers examined the quality of and results from peer-reviewed research on
ERT for mental disorders and related outcomes. Peer-reviewed studies (n = 14)
examining treatments for mental disorders or closely related outcomes were
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 18 of 36
identified from databases and article reference sections. All studies were
compromised by a substantial number of threats to validity, calling into question the
meaning and clinical significance of their findings. Additionally, studies failed to
provide consistent evidence that ERT is superior to the mere passage of time in the
treatment of any mental disorder. The authors concluded that the current evidence
base does not justify the marketing and utilization of ERT for mental disorders.
Such services should not be offered to the public unless and until well-designed
studies provide evidence that justify different conclusions.
Multiple Sclerosis
In a single-subject experimental design study (n = 11), Hammer and associates
(2005) examined whether therapeutic riding (TR, Sweden), also known as
hippotherapy (HT, United States) may affect balance, gait, spasticity, functional
strength, coordination, pain, self-rated level of muscle tension (SRLMT), activities of
daily living (ADL), and health-related quality of life in patients with multiple sclerosis
(MS). The intervention comprised 10 weekly TR/HT sessions of 30 mins each.
The subjects were measured a maximum of 13 times. Physical tests were: The
Berg balance scale, taking a figure of 8, the timed up and go test, 10-m walking, the
modified Ashworth scale, the Index of Muscle Function, the Birgitta Lindmark motor
assessment, part B, and individual measurements. Self-rated measures were: the
visual analog scale (VAS) for pain, a scale for SRLMT, the Patient-Specific
Functional Scale for ADL, and the Medical Outcomes Study 36-item Short-Form
health survey (SF-36). Data were analyzed visually, semi-statistically and
considering clinical significance. Results showed improvement for 10 subjects in
one or more of the variables, particularly balance, and some improvements were
also seen in pain, muscle tension, and ADL. Changes in SF-36 were mostly
positive, with an improvement in Role-Emotional seen in 8 patients. These
investigators concluded that balance and Role-Emotional were the variables most
often improved, but TR/HT appeared to benefit the subjects differently.
In a case-series study, Lindroth et al (2015) examined if there were observable
changes in sensory processing for postural control in individuals with MS following
physical therapy using HPOT or changes in balance and functional gait. This pre-
test non-randomized design study, with follow-up assessment at 6 weeks, included
2 females and 1 male (age range of 37 to 60 years) with diagnoses of relapse-
remitting or progressive MS. The intervention consisted of twelve 40-min physical
therapy sessions which included HPOT twice-weekly for 6 weeks. Sensory
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 19 of 36
organization and balance were assessed by the Sensory Organization Test (SOT)
and Berg Balance Scale (BBS). Gait was assessed using the Functional Gait
Assessment (FGA). Following the intervention period, all 3 participants showed
improvements in SOT (range of 1 to 8 points), BBS (range of 2 to 6 points), and
FGA (average of 4 points) scores. These improvements were maintained or
continued to improve at follow-up assessment; 2 of the 3 participants no longer over-
relied on vision and/or somatosensory information as the primary sensory input for
postural control, suggesting improved use of sensory information for balance. The
authors concluded that these findings indicated that HPOT may be a beneficial
physical therapy treatment strategy to improve balance, functional gait, and enhance
how some individuals with MS process sensory cues for postural control. Moreover,
they stated that randomized clinical trials are needed to validate results of this study.
Vermohlen and associates (2018) examined the effect of hippotherapy plus
standard care versus standard care alone in MS patients. A total of 70 adults with
MS were recruited in 5 German centers and randomly allocated to the intervention
group (12 weeks of hippotherapy) or the control group. Primary outcome was the
change in the Berg Balance Scale (BBS) after 12 weeks, and further outcome
measures included fatigue, pain, QOL, and spasticity. Co-variance analysis of the
primary end-point resulted in a mean difference in BBS change of 2.33 (95 % CI:
0.03 to 4.63, p = 0.047) between intervention (n = 32) and control (n = 38) groups.
Benefit on BBS was largest for the subgroup with an EDSS of greater than or equal
to 5 (5.1, p = 0.001). Fatigue (-6.8, p = 0.02) and spasticity (-0.9, p = 0.03) improved
in the intervention group. The mean difference in change between groups was 12.0
(p < 0.001) in physical health score and 14.4 (p < 0.001) in mental health score of
Multiple Sclerosis QOL-54 (MSQOL-54). The authors concluded that hippotherapy
plus standard care, while below the threshold of a minimal clinically important
difference, significantly improved balance and also fatigue, spasticity, and QOL in
MS patients.
Munoz-Lasa and colleagues (2019) stated that hippotherapy is a promising method in
the physical treatment of MS. These researchers carried out a comparative, open,
clinical pre-post study into hippotherapy intervention (non-randomized) during a 6-
month period in patients with MS (n = 6) and a h control group (n = 4). A statistically
significant improvement was observed in the therapy group in: spasticity pre-post
measured by the modified Ashworth scale (p = 0.01). Statistically significant
improvement in fatigue impact (p < 0.0001) measured with fatigue
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 20 of 36
impact scale (FIS); in general, perception of heath outcome in urinary QOL scale
King's Health Questionnaire (KHQ) (p = 0.033), and in subscales 2, 3 and 4 of
MSQOL-54 (p = 0.011). Control group showed no improvement in any scale. The
authors concluded that the findings of this study reinforced current literature that
supports hippotherapy as an adequate intervention for MS patients. Moreover, they
stated that further studies with more participants, control groups and blinded research
would be logical steps for future research in this field.
Anxiety and Post-Traumatic Stress Disorder
Earles and colleagues (2015) examined the effectiveness of the Equine Partnering
Naturally(©) approach to equine-assisted therapy for treating anxiety and post-
traumatic stress disorder (PTSD) symptoms. Participants were 16 volunteers who
had experienced a Criterion A traumatic event, such as a rape or serious accident,
and had current PTSD symptoms above 31 on the PTSD Checklist (PCL-S;
Weathers, Litz, Herman, Huska, and Keane). Participants engaged in tasks with
horses for 6 weekly 2-hour sessions. Immediately following the final session,
participants reported significantly reduced post-traumatic stress symptoms, d =
1.21, less severe emotional responses to trauma, d = 0.60, less generalized
anxiety, d = 1.01, and fewer symptoms of depression, d = 0.54. As well,
participants significantly increased mindfulness strategies, d = 1.28, and decreased
alcohol use, d = 0.58. There was no significant effect of the treatment on physical
health, proactive coping, self-efficacy, social support, or life satisfaction. Thus, the
authors found evidence that the Equine Partnering Naturally (©) approach to
equine-assisted therapy may be an effective treatment for anxiety and post-
traumatic stress symptoms. They stated that future research should include larger
groups, random assignment, and longer-term follow-up.
Attention Deficit and/or Hyperactivity Disorder
Lee and colleagues (2015) examined the effects of hippotherapy on brain function
and levels of blood-derived neurotrophic factor (BDNF) in children with attention
deficit and/or hyperactivity disorder (ADHD). The hippotherapy group (HRG) included
20 children with ADHD and the control group (CG) included 19 children. All
participants' physical fitness, functional magnetic resonance imaging (fMRI) brain
scans, and blood BDNF levels were measured at baseline and after 32 weeks of
participating in hippotherapy. After 32 weeks of participating in hippotherapy, the
body fat of the HRG was significantly decreased (-1.12 ± 4.20 %) and the body fat
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 21 of 36
of the CG was increased (2.38 ± 6.35 %) (p = 0.049). There was no significant
difference of physical fitness in both groups (p > 0.05). Although there was a higher
decrease in the activated insular area in the HRG (-1.59 ± 0.99) than in the CG (-
1.14 ± 1.41), there was no significant difference between the 2 groups (p > 0.05).
Furthermore, there was a higher increase in the activated cerebellum area in the
HRG (1.97 ± 1.45) than in the CG (1.92 ± 1.81). However, there was no significant
difference between the 2 groups (p > 0.05); BDNF levels showed an increased
tendency in the HRG (166.29 ± 277.52 pg) compared to the CG (21.13 ±
686.33 pg); otherwise, there was not any significant difference in these blood levels
between the 2 groups (p > 0.05). It can be assumed that big individual differences
in the level of ADHD in the study participants might not cause any significant
results, although there might be positive changes in the brain function of children
with ADHD. The authors concluded that the findings of this study suggested that
hippotherapy training would need to be modified and developed to increase the
effectiveness of hippotherapy in children with ADHD.
In a 12-week, prospective, open-label trial, Jang and associates (2015) examined
the clinical effects of equine-assisted activities and therapy (EAA/T) for treating
ADHD in children aged 6 to 13 years. This study entailed 24 sessions of EAA/T
with 20 participants (19 boys and 1 girl) completed 12 weeks of EAA/T. Various
clinical tests were administered at baseline and after EAA/T. Assessments included
the investigator-administered ADHD-Rating Scale (ARS-I), Clinical Global
Impressions-Severity Scale (CGI-S), Clinical Global Impressions-Improvement Scale
(CGI-I), Gordon Diagnostic System, Korea-Child Behavior Checklist
(K-CBCL), Self-Esteem Scale, second edition of the Bruininks-Oseretsky test of
motor proficiency (BOT-2), and quantitative electroencephalography. The primary
efficacy measure was the response rate. The response rate was 90 % based on a
30 % or greater decline in the ARS-I score or 85 % based on CGI-I scores of 1 or
2. The mean ± standard deviation ARS-I score decreased from 33.65 ± 6.42 at
baseline to 16.80 ± 6.86 after 12 weeks of EAA/T (p < 0.001, paired t-test). It was
reported that EAA/T also resulted in significant improvement in the social problems
subscale of the K-CBCL and in the manual dexterity, bilateral coordination, and total
motor composite subscales of the BOT-2. The theta/beta ratio on
electroencephalography was decreased significantly at the Pz electrode after 12
weeks of EAA/T. The authors concluded that this was the first study demonstrating
that EAA/T is effective for improving core ADHD symptoms. They stated that on
the basis of these results, EAA/T could be a viable treatment strategy as a part of a
multi-modal therapy for children with ADHD. The main drawbacks of this study
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 22 of 36
were its small sample size (n = 20), short-term follow-up (12 weeks) and its open-
label design. These preliminary findings need to be validated by well-designed
studies.
Furthermore, an UpToDate review on “Attention deficit hyperactivity disorder in
children and adolescents: Overview of treatment and prognosis” (Krull, 2015) does
not mention hippotherapy as a therapeutic option.
In a pilot study, Yoo and colleagues (2016) examined the effects of EAA/T on
participants with ADHD by comparing resting-state fMRI (rs-fMRI) signals and their
clinical correlates. A total of 10 subjects with ADHD participated in a 12-week
EAA/T program without any medication; 2 rs-fMRIs were acquired for all subjects
before and after EAA/T. For estimating therapeutic effect, the regional
homogeneity (ReHo) method was applied to capture the changes in the regional
synchronization of functional signals. After the EAA/T program, clear symptom
improvement was found even without medication. Surface-based pair-wise
comparisons revealed that ReHo in the right precuneus and right pars orbitalis
clusters had significantly diminished after the program. Reduced ReHo in the right
precuneus cluster was positively correlated with changes in the scores on DuPaul's
ADHD Rating Scale-Korean version. The authors concluded that these findings
indicated that EAA/T is associated with short-range functional connectivity in the
regions related to the default mode network and the behavioral inhibition system,
which are associated with symptom improvement. They stated that for equine
therapy to be accepted as an adjunct therapeutic option for ADHD, additional
studies with larger samples, controlled designs, and purposeful fMRI sessions are
needed.
This pilot study had several drawbacks: (i) the study included only a subset of
ADHD subjects who finished the 12-weeks of EAA/T. Comparison with the typically
developing children would be needed in the future, (ii) these researchers only
analyzed resting-state data, and thus, the direct effects of EAA/T on task-related
performance such as attention, emotion, and cognition could not be estimated.
Investigating those effects requires task-specific fMRI designs for each domain, and
(iii) long-term effects could not be examined from a single 12-week EAA/T session.
Lee and colleagues (2017) examined the effect of hippotherapy and
electroencephalography (EEG) neurofeedback on brain function and blood BDNF
level in children with ADHD. A total of 16 children with ADHD participated in this
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 23 of 36
study and were randomly divided into 2 groups: (i) a 1-time hippotherapy group
(W1G, n = 8), and (ii) a 2-time hippotherapy group (W2G, n = 8). All the
participants attended 8 weeks of hippotherapy program in the primary training, and
then 7 children with ADHD attended 8 weeks of hippotherapy program combined
with neurofeedback training in the secondary training. Blood BDNF levels were
measured, and fMRI was performed. The EEG neurofeedback training program
was used to train and measure psychological factors. The combined effect of
hippotherapy and neurofeedback on BDNF level showed a decreased tendency in
W1G (pre-training, 1,766.03 ± 362.54 pg/ml; post-training, 1,630.65 ± 276.70
pg/ml). However, the BDNF level of W2G showed an increased tendency (pre-
training, 1,968.28 ± 429.08 pg/ml; post-training, 1,976.28 ± 425.35 pg/ml).
Moreover, combined training showed a significant group x repetition interaction in
W1G (pre-training, 1,436.57 ± 368.76 pg/ml; post-training, 1,525.23 ± 346.22 pg/ml;
F = 3.870, p = 0.039); fMRI results showed that the left thalamus activity in both
groups had a decreased tendency and a significantly lower change in W2G than in
W1G (p < 0.05). The authors concluded that the findings of this study suggested
that hippotherapy combined with various psychological interventions would be
useful for improving brain function in children with ADHD. Moreover, they
recommended that future studies consider consistency of ADHD level and unified
exercise intensity application for better understanding of the effects of hippotherapy
and neurofeedback training on children with ADHD.
This study had 2 major drawbacks: (i) the ADHD level of each subject might be
inconsistent, which might have negatively affected the study results, and (ii)
the progress of each subject in hippotherapy differed because of the different
levels of learning ability. This might have caused a variation in exercise intensity,
although the study set the same exercise intensity.
Oh, and co-workers (2018) examined the effects of hippotherapy versus
pharmacotherapy for children with ADHD. A total of 34 subjects with ADHD were
randomly assigned at a 1:1 ratio to either 24 sessions of a twice-weekly
hippotherapy or pharmacotherapy. To assess therapeutic effects, the ARS was
used pre-treatment and post-treatment as the primary outcome measure.
Secondary outcomes included the CBCL, Self-Esteem Scale (SES), PedsQL child
and parent report version, Developmental Coordination Disorder Questionnaire
(DCDQ), CGI-S, and quantitative electroencephalography (qEEG). Both groups
showed marked improvements in ADHD symptoms, CGI-S. No significant
differences between the 2 groups were detected regarding treatment outcome
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 24 of 36
except thought problem subscales of CBCL; 12 weeks of hippotherapy improved
attention, impulsivity/hyperactivity, and QOL. The authors concluded that the
findings of this trial are promising, but further studies are needed to evaluate the
long-term clinical effectiveness of hippotherapy.
Sexual Abuse and Emotional Stress
Guerino et al (2015) evaluated 2 women aged 18 and 21 years, who had suffered
sexual violence when they were children between the ages of 6 and 7 years old.
The subjects did not have mental dysfunction, but they were regular students
registered at a school of special education; patients presented with severe motor
limitation, difficulty with coordination, significant muscular retractions, thoracic and
cervical kyphosis, cervical protrusion, which was basically a function of the postures
they had adopted when they were victims of the sexual violence suffered in
childhood. The patients performed 20 sessions of 30-min of HPOT on a horse.
The activities were structured to stimulate coordination, proprioception, the
vestibular and motor-sensorial systems for the improvement of posture, muscle
activity and cognition. The activities provided during HPOT sessions elicited
alterations in postural adjustment resulting in 30 % improvement, 80 %
improvement in coordination in, 50 % improvement in corporal balance and in
sociability and self-esteem. The authors concluded that HPOT proved to be an
effective treatment method for coordination, balance and postural correction, and
also improved the patients' self-esteem that had suffered serious emotional stress.
These preliminary findings need to be validated by well-designed studies.
Traumatic Brain Injury
In a single-case study, Erdman and Pierce (2016) described the use of
hippotherapy with a boy who sustained a traumatic brain injury (TBI). A 13-year old
boy, 6 months after TBI received 12 physical therapy sessions, which included
hippotherapy. Improvements were noted in balance, strength, gross motor skills,
gait speed, functional mobility, and reported participation. The authors concluded
that hippotherapy used with a 13-year old boy after TBI may have had a positive
effect in the body structure, activity, and participation domains. These preliminary
findings need to be validated by well-designed studies.
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 25 of 36
Rigby and Grandjean (2016) summarized the physical benefits of therapeutic
horseback riding and hippotherapy and suggested directions for future research.
Databases included Medline via Ebsco, Web of Science, PubMed, Google Scholar,
and Academic Search Complete. Articles were limited to those with full-text access
published in English since 1987. Acute and residual improvements in physical
benefits, such as gross motor function (e.g., walking, running, jumping), spasticity,
muscle symmetry, posture, balance, and gait occurred in adults and children with
varying disabilities. The benefits appeared to be greatest following multi-week
interventions with 1 or more sessions per week. Modest acute cardiovascular
responses were observed during EAA/T with little or no evidence for training
improvements in heart rate or blood pressure at rest or during riding. The authors
concluded that the present body of literature provided evidence that EAA/T are an
effective means of improving many measures of physical health. However, more
controlled trials are urgently needed to strengthen the current knowledge base,
establish dose-response characteristics of EAA/T, and explore the physiologic
basis for the promising results suggested from the literature.
Marquez and associates (2018) stated that evaluation of the merit of hippotherapy
in adults with acquired brain injury (ABI) is lacking. These researchers examined if
hippotherapy could improve motor function in adults with ABI. They carried out a
systematic review of all available controlled studies investigating the use of
hippotherapy, in adults with ABI. The primary outcome of interest was movement
related function and secondary outcomes included impairment, QOL, and adverse
events (AEs). A total of 9 studies with 256 participants were included, of which 6
studies with 204 participants were included for meta-analysis. When the data were
pooled, hippotherapy did not produce statistically significant improvements in
balance (standard mean difference [SMD] = 0.24, 95 % CI: -0.05, 0.54, p = 0.1) or
gait parameters (SMD = -0.04, 95 % CI: -0.79, 0.72 p = 0.92) when compared to
control and measured immediately after the intervention. Long-term effects remain
unknown due to lack of follow-up evaluation. The authors concluded that the
findings of this review suggested that hippotherapy is safe and well-tolerated by
adults with ABI; short-term functional benefits were not associated with the use of
hippotherapy. These investigators stated that further high-quality research is
needed before hippotherapy can be endorsed as a modality in adult neurological
rehabilitation.
Substance Abuse Disorder
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 26 of 36
Kern-Godal et al (2016) noted that inclusion of horse-assisted therapy (HAT) in
substance abuse disorder treatment is rarely reported. The authors’ previous
studies showed improved treatment retention and the importance of the patient-
horse relationship. This qualitative study used thematic analysis, within a social
constructionist framework, to explore how 8 patients experienced contextual
aspects of HAT's contribution to their substance abuse disorder treatment.
Participants described HAT as a "break from usual treatment". However, 4
interrelated aspects of this experience, namely "change of focus", "activity",
"identity", and "motivation," suggested HAT is more than just a break from usual
substance abuse disorder treatment. The stable environment is portrayed as a
context where participants could construct a positive self: one which is useful,
responsible, and accepted; more fundamentally, a different self from the
“patient/self" receiving treatment for a problem. The authors concluded that the
implications extend well beyond animal-assisted or other adjunct therapies; and
their relevance to broader substance abuse disorder policy and treatment practices
warrants further study.
Autism Spectrum Disorder
In a pilot study, Ajzenman et al (2013) examined if hippotherapy increased function
and participation in children with autism spectrum disorder (ASD). These
researchers hypothesized improvements in motor control, which might increase
adaptive behaviors and participation in daily activities. A total of 6 children with
ASD aged 5 to 12 participated in 12 weekly 45-min hippotherapy sessions.
Measures pre- and post-hippotherapy included the Vineland Adaptive Behavior
Scales-II and the Child Activity Card Sort. Motor control was measured pre-
intervention and post-intervention using a video motion capture system and force
plates. Postural sway significantly decreased post-intervention. Significant increases
were observed in overall adaptive behaviors (receptive communication and coping)
and in participation in self-care, low-demand leisure, and social interactions. The
authors concluded that these results suggested that hippotherapy has a positive
influence on children with ASD and can be a useful treatment tool for this population.
The findings of this small, pilot study need to be validated by well- designed studies.
O'Haire (2013) stated that the inclusion of animals in therapeutic activities, known
as animal-assisted intervention (AAI), has been suggested as a treatment practice
for ASD. These investigators presented a systematic review of the empirical
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 27 of 36
research on AAI for ASD. A total of 14 studies published in peer-reviewed journals
qualified for inclusion. The presentation of AAI was highly variable across the
studies. Reported outcomes included improvements for multiple areas of
functioning known to be impaired in ASD, namely increased social interaction and
communication as well as decreased problem behaviors, autistic severity, and
stress. The author concluded that despite unanimously positive outcomes, most
studies were limited by many methodological weaknesses; this review showed that
there is preliminary "proof of concept" of AAI for ASD and high-lighted the need for
further, more rigorous research.
Srinivasan and colleagues (2018) noted that literature on effects of equine therapy
in individuals with ASD has grown in recent times. Equine therapy is an alternative
multi-modal intervention that involves utilizing a horse to enhance core impairments
in ASD. Recent systematic reviews in this area have several limitations including
inclusion of populations other than ASD, assessment of a variety of animal-assisted
interventions other than equine therapy, and a failure to conduct quantitative
analyses to provide accurate effect size estimates. These investigators conducted
a focused systematic review to address these limitations. This review suggested
that equine therapy has beneficial effects on behavioral skills and to some extent
on social communication in ASD. The authors concluded that the evidence for
positive effects of equine therapy on perceptuo-motor, cognitive, and functional skills
is currently limited.
Down's Syndrome
De Miguel and colleagues (2018) noted that Down's syndrome is the main cause of
intellectual disability and the most common human genetic alteration. Motor
impairments are among the most important alterations presented by Down's
syndrome subjects. Hippotherapy is currently being used as a therapy to correct
those dysfunctions. These investigators review published literature on the effect of
hippotherapy on the gross motor function of people with Down's syndrome. The
bibliography in the following databases has been widely searched: CINAHL,
Medline, the Cochrane Library, PEDro, Scopus, and Web of Science. The journals
Fisioterapia and Cuestiones de Fisioterapia have also been consulted. The
electronic literature search strategy was addressed in 2 thematic fields: Down's
syndrome and hippotherapy. Studies selection was carried out following inclusion
and exclusion criteria and rejecting duplicate papers. That search included articles
published between 2000 and 2016. A total of 23 articles were found, 15 of which
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 28 of 36
were discarded for different reasons, leaving 8 valid ones. The authors concluded
that there is no strong evidence on the improvement of gross motor function in
people with Down's syndrome after treatment with hippotherapy. They stated that
more studies with higher methodological quality are needed to verify the
effectiveness of hippotherapy in the treatment of gross motor function in subjects
with Down's syndrome.
Low Back Pain
In a randomized, single-blind, clinical trial, Rahbar and colleagues (2018) evaluated
the effects of a hippotherapy simulator on pain, disability, and range of motion
(ROM) of the spinal column in subjects with mechanical low back pain (LBP). A
total of 80 subjects were randomly assigned to either the control or intervention
groups. All subjects underwent routine physiotherapy. In addition, the intervention
group underwent hippotherapy with a hippotherapy simulator for 15 sessions, each
lasting 15 mins. Pain, disability, and ROM of the lumbar spinal column of the
subjects were measured in the first and last physiotherapy sessions respectively.
Improvement in pain intensity was higher in the hippotherapy simulator group over
the first 8 days of treatment (hippotherapy versus control point changes: Day 12: p
= 0.010; after treatment: p = 0.005). The hippotherapy simulator group had
significantly higher improvement in disability score in comparison to the control
group (p < 0.001); mean changes in the modified Schober test were not significant
(p = 0.423). The authors concluded that the hippotherapy simulator decreased pain
and disability in subjects with LBP; however, no additional improvement in lumbar
spine ROM was observed. This study used a hippotherapy simulator; its findings
need to be validated in the “real world” hippotherapy setting.
CPT Codes / HCPCS Codes / ICD-10 Codes
Information in the [brackets] below has been added for clarification purposes. Codes requiring a 7th character are represented by "+":
HCPCS codes not covered for indications listed in the CPB:
ICD-10 codes not covered for indications listed in the CPB (not all-inclusive):
A88.1
F01.50 - F99
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 29 of 36
F50.00 - F50.9
G80.0 - G80.9
H81.01 - H82.9
H83.2X1 -
H83.2X9
I60.00 - I69.998 Cerebrovascular diseases
M00.00 - M99.9
R25.0 - R29.9
R42
R48.0 - R48.9
R62.0 - R62.7
R63.2 Polyphagia
R68.0 - R68.89
S02.0XX+ -
S02.92X+
S02.0XXS -
S02.92XS
S06.0X0+ -
S06.9X9+
S06.0X0S -
S06.9X9S
S09.0X+ -
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 30 of 36
T76.21 - T76.22
Z62.810
Z73.3
Z87.81
Z87.820
Z91.411
The above policy is based on the following references:
1. Haskin M, Bream JA, Erdman WJ 2nd. The Pennsylvania horseback riding
program for cerebral palsy. Am J Phys Med. 1982;61(3):141-144.
2. Tuttle JI. The horse as member of a therapeutic team. Rehab Nursing.
1987;12(60):334-335.
3. Bertoti DB. Effect of therapeutic horseback riding on posture in children
with cerebral palsy. Phys Ther. 1988;68(10):1505-1512.
4. National Institutes of Health (NIH), Office of Medical Applications of
Research (OMAR). The health benefits of pets. OMAR Workshop,
September 10-11, 1987. NIH Technology Assessment Statement 3.
Bethesda, MD: NIH; 1987.
5. Potter JT, Evans JW, Nolt BH Jr. Therapeutic horseback riding. J Am Vet Med
Assoc. 1994;204(1):131-133.
6. McGibbon NH, Andrade CK, Widener G, Cintas HL. Effect of an equine-
movement therapy program on gait, energy expenditure, and motor
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 31 of 36
function in children with spastic cerebral palsy: A pilot study. Dev Med
Child Neurol. 1998;40(11):754-762.
7. Benda W, McGibbon NH, Grant KL. Improvements in muscle symmetry in
children with cerebral palsy after equine-assisted therapy (hippotherapy). J
Altern Compl Med. 2003;9(6):817-825.
8. Hammer A, Nilsagard Y, Forsberg A, et al. Evaluation of therapeutic riding
(Sweden)/hippotherapy (United States). A single-subject experimental
design study replicated in eleven patients with multiple sclerosis.
Physiother Theory Pract. 2005;21(1):51-77.
9. Debuse D, Chandler C, Gibb C. An exploration of German and British
physiotherapists' views on the effects of hippotherapy and their
measurement. Physiother Theory Pract. 2005;21(4):219-242.
10. Casady RL, Nichols-Larsen DS. The effect of hippotherapy on ten children
with cerebral palsy. Pediatr Phys Ther. 2004;16(3):165-172.
11. Liptak GS. Complementary and alternative therapies for cerebral palsy.
Ment Retard Dev Disabil Res Rev. 2005;11(2):156-163.
12. Pichon Riviere A, Augustovski F, Alcaraz A, et al. Usefulness of
hippotherapy [summary]. Report ITB No. 28. Buenos Aires, Argentina:
Institute for Clinical Effectiveness and Health Policy (IECS); 2006.
13. Snider L, Korner-Bitensky N, Kammann C, et al. Horseback riding as
therapy for children with cerebral palsy: Is there evidence of its
effectiveness? Phys Occup Ther Pediatr. 2007;27(2):5-23.
14. Centre for Reviews and Dissemination (CRD). Horseback riding as therapy
for children with cerebral palsy: Is there evidence of its effectiveness?
Database of Abstracts of Reviews of Effectiveness (DARE). York, UK:
University of York; 2009.
15. Lechner HE, Kakebeeke TH, Hegemann D, Baumberger M. The effect of
hippotherapy on spasticity and on mental well-being of persons with
spinal cord injury. Arch Phys Med Rehabil. 2007;88(10):1241-1248.
16. Hamill D, Washington KA, White OR. The effect of hippotherapy on postural
control in sitting for children with cerebral palsy. Phys Occup Ther Pediatr.
2007;27(4):23-42.
17. Sterba JA. Does horseback riding therapy or therapist-directed
hippotherapy rehabilitate children with cerebral palsy? Dev Med Child
Neurol. 2007;49(1):68-73.
18. Centre for Reviews and Dissemination (CRD). Does horseback riding
therapy or therapist-directed hippotherapy rehabilitate children with
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 32 of 36
cerebral palsy? Database of Abstracts of Reviews of Effectiveness (DARE).
York, UK: University of York; 2008.
19. McGibbon NH, Benda W, Duncan BR, Silkwood-Sherer D. Immediate and
long-term effects of hippotherapy on symmetry of adductor muscle
activity and functional ability in children with spastic cerebral palsy. Arch
Phys Med Rehabil. 2009;90(6):966-974.
20. McGee MC, Reese NB. Immediate effects of a hippotherapy session on gait
parameters in children with spastic cerebral palsy. Pediatr Phys Ther.
2009;21(2):212-218.
21. Oppenheim WL. Complementary and alternative methods in cerebral
palsy. Dev Med Child Neurol. 2009;51 Suppl 4:122-129.
22. Johnson CC. The benefits of physical activity for youth with developmental
disabilities: A systematic review. Am J Health Promot. 2009;23(3):157-167.
23. Shurtleff TL, Engsberg JR. Changes in trunk and head stability in children
with cerebral palsy after hippotherapy: A pilot study. Phys Occup Ther
Pediatr. 2010;30(2):150-163.
24. Bronson C, Brewerton K, Ong J, et al. Does hippotherapy improve balance
in persons with multiple sclerosis: A systematic review. Eur J Phys Rehabil
Med. 2010;46(3):347-353.
25. Zadnikar M, Kastrin A. Effects of hippotherapy and therapeutic horseback
riding on postural control or balance in children with cerebral palsy: A
meta-analysis. Dev Med Child Neurol. 2011;53(8):684-691.
26. Munoz-Lasa S, Ferriero G, Valero R, et al. Effect of therapeutic horseback
riding on balance and gait of people with multiple sclerosis. G Ital Med Lav
Ergon. 2011;33(4):462-467.
27. Whalen CN, Case-Smith J. Therapeutic effects of horseback riding therapy
on gross motor function in children with cerebral palsy: A systematic
review. Phys Occup Ther Pediatr. 2012;32(3):229-242.
28. Tseng SH, Chen HC, Tam KW, et al. Systematic review and meta-analysis of
the effect of equine assisted activities and therapies on gross motor
outcome in children with cerebral palsy. Disabil Rehabil. 2013;35(2):89-99.
29. Manikowska F, Jozwiak M, Idzior M, et al. The effect of a hippotherapy
session on spatiotemporal parameters of gait in children with cerebral
palsy - pilot study. Ortop Traumatol Rehabil. 2013;15(3):253-257.
30. Beinotti F, Christofoletti G, Correia N, Borges G. Effects of horseback riding
therapy on quality of life in patients post stroke. Top Stroke Rehabil.
2013;20(3):226-232.
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 33 of 36
31. Ajzenman HF, Standeven JW, Shurtleff TL. Effect of hippotherapy on motor
control, adaptive behaviors, and participation in children with autism
spectrum disorder: A pilot study. Am J Occup Ther. 2013;67(6):653-663.
32. O'Haire ME. Animal-assisted intervention for autism spectrum disorder: A
systematic literature review. J Autism Dev Disord. 2013;43(7):1606-1622.
33. Homnick DN, Henning KM, Swain CV, Homnick TD. Effect of therapeutic
horseback riding on balance in community-dwelling older adults with
balance deficits. J Altern Complement Med. 2013;19(7):622-626.
34. Dezutti JE. Eating disorders and equine therapy: A nurse's perspective on
connecting through the recovery process. J Psychosoc Nurs Ment Health
Serv. 2013;51(9):24-31.
35. Park ES, Rha DW, Shin JS, et al. Effects of hippotherapy on gross motor
function and functional performance of children with cerebral palsy.
Yonsei Med J. 2014;55(6):1736-1742.
36. Cerulli C, Minganti C, De Santis C, et al. Therapeutic horseback riding in
breast cancer survivors: A pilot study. J Altern Complement Med. 2014;20
(8):623-629.
37. Nurenberg JR, Schleifer SJ, Shaffer TM, et al. Animal-assisted therapy with
chronic psychiatric inpatients: Equine-assisted psychotherapy and
aggressive behavior. Psychiatr Serv. 2015;66(1):80-86.
38. Del Rosario-Montejo O, Molina-Rueda F, Munoz-Lasa S, Alguacil-Diego IM.
Effectiveness of equine therapy in children with psychomotor impairment.
Neurologia. 2015;30(7):425-432.
39. Anestis MD, Anestis JC, Zawilinski LL, et al. Equine-related treatments for
mental disorders lack empirical support: A systematic review of empirical
investigations. J Clin Psychol. 2014;70(12):1115-1132.
40. Dewar R, Love S, Johnston LM. Exercise interventions improve postural
control in children with cerebral palsy: A systematic review. Dev Med Child
Neurol. 2015;57(6):504-520.
41. Miller G. Management and prognosis of cerebral palsy. UpToDate [online
serial]. Waltham, MA: UpToDate; reviewed November 2015.
42. Lindroth JL, Sullivan JL, Silkwood-Sherer D. Does hippotherapy effect use of
sensory information for balance in people with multiple sclerosis?
Physiother Theory Pract. 2015;31(8):575-581.
43. Earles JL, Vernon LL, Yetz JP. Equine-assisted therapy for anxiety and
posttraumatic stress symptoms. J Trauma Stress. 2015;28(2):149-152.
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 34 of 36
44. Guerino MR, Briel AF, Araújo Md. Hippotherapy as a treatment for
socialization after sexual abuse and emotional stress. J Phys Ther Sci.
2015;27(3):959-962.
45. Lee N, Park S, Kim J. Effects of hippotherapy on brain function, BDNF level,
and physical fitness in children with ADHD. J Exerc Nutrition Biochem.
2015;19(2):115-121.
46. Jang B, Song J, Kim J, et al. Equine-assisted activities and therapy for
treating children with attention-deficit/hyperactivity disorder. J Altern
Complement Med. 2015;21(9):546-553.
47. Krull KR. Attention deficit hyperactivity disorder in children and
adolescents: Overview of treatment and prognosis. UpToDate [online
serial]. Waltham, MA: UpToDate; reviewed November 2015.
48. Lee PT, Dakin E, McLure M. Narrative synthesis of equine-assisted
psychotherapy literature: Current knowledge and future research
directions. Health Soc Care Community. 2016 May;24(3):225-246.
49. Yoo JH, Oh Y, Jang B, et al. The effects of equine-assisted activities and
therapy on resting-state brain function in attention-deficit/hyperactivity
disorder: A pilot study. Clin Psychopharmacol Neurosci. 2016;14(4):357
364.
50. Erdman EA, Pierce SR. Use of hippotherapy with a boy after traumatic
brain injury: A case study. Pediatr Phys Ther. 2016;28(1):109-116.
51. Rigby BR, Grandjean PW. The efficacy of equine-assisted activities and
therapies on improving physical function. J Altern Complement Med.
2016;22(1):9-24.
52. Kern-Godal A, Brenna IH, Arnevik EA, Ravndal E. More than just a break
from treatment: How substance use disorder patients experience the
stable environment in horse-assisted therapy. Subst Abuse. 2016; 10:99
108.
53. McDaniel Peters BC, Wood W. Autism and equine-assisted interventions: A
systematic mapping review. J Autism Dev Disord. 2017;47(10):3220-3242.
54. Lee N, Park S, Kim J. Hippotherapy and neurofeedback training effect on
the brain function and serum brain-derived neurotrophic factor level
changes in children with attention-deficit or/and hyperactivity disorder. J
Exerc Nutrition Biochem. 2017;21(3):35-42.
55. Vermohlen V, Schiller P, Schickendantz S, et al. Hippotherapy for patients
with multiple sclerosis: A multicenter randomized controlled trial (MS
HIPPO). Mult Scler. 2018;24(10):1375-1382.
Proprietary
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019
Page 35 of 36
56. Oh Y, Joung YS, Jang B, et al. Efficacy of hippotherapy versus
pharmacotherapy in attention-deficit/hyperactivity disorder: A randomized
clinical trial. J Altern Complement Med. 2018;24(5):463-471.
57. Srinivasan SM, Cavagnino DT, Bhat AN. Effects of equine therapy on
individuals with autism spectrum disorder: A systematic review. Rev J
Autism Dev Disord. 2018;5(2):156-175.
58. De Miguel A, De Miguel MD, Lucena-Anton D, Rubio MD. Effects of
hypotherapy on the motor function of persons with Down's syndrome: A
systematic review. Rev Neurol. 2018;67(7):233-241.
59. Rahbar M, Salekzamani Y, Jahanjou F, et al. Effect of hippotherapy
simulator on pain, disability and range of motion of the spinal column in
subjects with mechanical low back pain: A randomized single-blind clinical
trial. J Back Musculoskelet Rehabil. 2018;31(6):1183-1192.
60. Marquez J, Weerasekara I, Chambers L. Hippotherapy in adults with
acquired brain injury: A systematic review. Physiother Theory Pract. 2018
Jul 17:1-12 [Epub ahead of print].
61. Munoz-Lasa S, Lopez de Silanes C, Atín-Arratibel MA, et al. Effects of
hippotherapy in multiple sclerosis: Pilot study on quality of life, spasticity,
gait, pelvic floor, depression and fatigue. Med Clin (Barc). 2019;152(2):55
58.
Page 36 of 36
Copyright Aetna Inc. All rights reserved. Clinical Policy Bulletins are developed by Aetna to assist in administering plan
benefits and constitute neither offers of coverage nor medical advice. This Clinical Policy Bulletin contains only a partial,
general description of plan or program benefits and does not constitute a contract. Aetna does not provide health care
services and, therefore, cannot guarantee any results or outcomes. Participating providers are independent contractors in
private practice and are neither employees nor agents of Aetna or its affiliates. Treating providers are solely responsible
for medical advice and treatment of members. This Clinical Policy Bulletin may be updated and therefore is subject to
change.
Copyright © 2001-2019 Aetna Inc.
http://qawww.aetna.com/cpb/medical/data/100_199/0151_draft.html 04/25/2019 Proprietary
AETNA BETTER HEALTH® OF PENNSYLVANIA
Amendment to Aetna Clinical Policy Bulletin Number: 0151 Hippotherapy
There are no amendments for Medicaid.
www.aetnabetterhealth.com/pennsylvania revised 02/14/2019